NPC1L1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, newer data indicate that NPC1L1 may also play a role in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [8].